Shoshana Keren-Rosenberg

Original p53 status predicts for pathological response in locally advanced breast cancer patients treated preoperatively with continuous infusion 5-Fluorouracil and radiation therapy

Silvia C. Formenti, Gary L. Dunnington, Beatrice Uzieli et al. · International Journal of Radiation Oncology*Biology*Physics · 1997 · 61 citations

Medicine, Oncology, Radiation Oncology +16

Real-world experience with capmatinib in <i>MET</i> exon 14-mutated non-small cell lung cancer (RECAP): a retrospective analysis from an early access program

Oliver Illini, Hannah Fabikan, Aurélie Swalduz et al. · Therapeutic Advances in Medical Oncology · 2022 · 29 citations · Full text

Medicine, Oncology, Pharmacology +17

Dose escalation of osimertinib for intracranial progression in EGFR mutated non-small-cell lung cancer with brain metastases

Iris M. Goldstein, Laila C. Roisman, Shoshana Keren-Rosenberg et al. · Neuro-Oncology Advances · 2020 · 27 citations · Full text

Medicine, Oncology, Pharmacology +17

Osimertinib in advanced EGFR-mutant lung adenocarcinoma with asymptomatic brain metastases: an open-label, 3-arm, phase II pilot study

Nir Peled, Waleed Kian, Edna Inbar et al. · Neuro-Oncology Advances · 2021 · 23 citations · Full text

Medicine, Oncology, Pharmacology +17

Neoadjuvant Osimertinib Followed by Sequential Definitive Radiation Therapy and/or Surgery in Stage III Epidermal Growth Factor Receptor–Mutant Non-Small Cell Lung Cancer: An Open-Label, Single-Arm, Phase 2 Study

Nir Peled, Laila C. Roisman, Esther Levison et al. · International Journal of Radiation Oncology*Biology*Physics · 2023 · 23 citations

Medicine, Oncology, Radiation Oncology +14